Gland Pharma Ltd 2025 Annual Report with Sustainability Disclosures
Company: Gland Pharma Ltd
Sector: Manufacturing
Country: India
Year: 2025
Type: Annual Report with Sustainability Disclosures
Pages: 334
The report presents Gland Pharma's FY 2024-25 consolidated revenue of ₹56,165.04 million alongside a strong focus on operational resilience and innovation. It reports 95.15 GWh of total energy consumed and 3.54% additional energy derived from renewable sources. The report also records zero fatalities across manufacturing facilities and highlights resource-efficiency initiatives, including waste utilisation and water recycling.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.